Trademark Details For SYNOLIGO (Serial Number 97668963)

  •  Home
  •  Print
SYNOLIGO
0
0
0
0
Basic Information
Serial Number  United States - USPTO 97668963
Registration Number 7329395
Mark
SYNOLIGO
Filing Date Nov-09-2022
Status
Registered  
REGISTERED (700)
REGISTERED
Attorney Name
TTAB
0
Action Tags
  


  • SYNOLIGO BIOTECHNOLOGIES, INC.


001Chemicals

U.S Class(es): 001, 005, 006, 010, 026, 046

Class Status: Active

First Use: Jun-30-2022

First Use in Commerce: Jan-04-2023

005Pharmaceuticals

U.S Class(es): 005, 006, 018, 044, 046, 051, 052

Class Status: Active

First Use: Jun-30-2023

First Use in Commerce: Jan-04-2023





Correspondences

NameSynoligo Biotechnologies, Inc.
Address101 SOUTHCENTER COURT, SUITE 800 MORRISVILLE, NC 27560

Prosecution History

  
USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Nov-12-2022NEW APPLICATION ENTERED   NWAPI
Nov-29-2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Aug-23-2023ASSIGNED TO EXAMINER   DOCKD
Aug-28-2023EXAMINERS AMENDMENT -WRITTEN   CNEAR
Aug-28-2023EXAMINERS AMENDMENT E-MAILED   GNEAF
Aug-28-2023
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
  
GNENO
Aug-28-2023EXAMINER'S AMENDMENT ENTERED   XAECI
Aug-31-2023APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAP
Sep-20-2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Oct-10-2023PUBLISHED FOR OPPOSITION   PUBOA
Oct-10-2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Dec-05-2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT   NOAME
Dec-22-2023TEAS STATEMENT OF USE RECEIVED   EISUI
Jan-13-2024CASE ASSIGNED TO INTENT TO USE PARALEGAL   AITUA
Dec-22-2023USE AMENDMENT FILED   IUAFS
Jan-13-2024STATEMENT OF USE PROCESSING COMPLETE   SUPCI
Feb-07-2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED   CNPRP
Feb-08-2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED   SUNAE
Mar-12-2024REGISTERED-PRINCIPAL REGISTER   R.PRA
Mar-12-2024NOTICE OF REGISTRATION CONFIRMATION EMAILED   NRCCE